Consider Orilissa for Some Women With Endometriosis

October 2018

New Rx Orilissa (or-ih-LIH-sah, elagolix) will increase focus on how to manage endometriosis.

Up to 10% of reproductive-age women have endometrial tissue that grows outside of the uterus...which can lead to dysmenorrhea, pelvic pain, dyspareunia, and possibly infertility.

Continue to recommend an NSAID for dysmenorrhea.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Sort Out Influenza Vaccine Options for 2018-19
Cardiology Address Depression in Post-MI Patients
Pregnancy Use FDA's Updated System to Decipher Med Safety in Pregnancy
Dermatology Help Get to the Bottom of Diaper Rash
Hematology & Oncology Watch for Autoimmune-Like Effects From Cancer Immunotherapy
Pharmacogenetics Don't Recommend Pharmacogenetic Testing for Most Patients
Endometriosis Consider Orilissa for Some Women With Endometriosis
Natural Medicines Focus on Safety if Patients Use Essential Oils
Generics Prepare for Generic Tadalafil and Vardenafil
HIV & AIDS Expect Integrase Inhibitors to Gain an Edge in Treating HIV
Epinephrine Be Ready for Questions About EpiPen Shortages and Generics
Antipsychotics Compare Aristada Initio and Perseris to Other Injectable Antipsychotics
Medicare Be Ready for Questions About 2019 Medicare Part D Changes

Consider Orilissa for Some Women With Endometriosis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents